IL33 and arthritic joint disease: On a cellular and cytokine level, IVIg was reported to induce a Th2-type immune response with production of interleukin 33 (IL33) and IL4, leading to an increased expression of FcγRIIB on splenic macrophages in a murine arthritis model (17).